Tag Archives: testing

Breast screening, cancer treatments and cardiovascular disease

This article highlights serious risks to cardiovascular health caused by breast cancer treatments (which need to be considered as part of overdiagnosis and overtreatment due to breast screening mammography). ‘…current breast cancer treatments can have a negative impact on cardiovascular … Continue reading

Posted in Breast Cancer, breast screening, Campaigns, cancer, citizen safety, Compassion in healthcare, healthcare modernisation, informed consent, medicine's flaws, Over-medicalisation, overdiagnosis, overtreatment, personal autonomy, Public safety, Screening, Screening Mammography | Tagged , , , , | Leave a comment

Breast screening: effectiveness (or otherwise) and harm

This BMJ article concludes that the Dutch mammography screening programme appears to have little impact on the number of advanced breast cancers – a marginal effect on breast cancer mortality – and half the screen detected cancers represent overdiagnosis (which … Continue reading

Posted in Breast Cancer, breast screening, Campaigns, harms, healthcare modernisation, Over-medicalisation, overdiagnosis, overtreatment, Public safety, Screening, Screening Mammography | Tagged , , | Leave a comment

‘Breast Cancer Screening -Better without mammograms?’

“Conclusions: The Dutch mammography screening programme seems to have little impact on the burden of advanced breast cancers, which suggests a marginal effect on breast cancer mortality. About half of screen detected breast cancers would represent over-diagnosis.” Here is yet … Continue reading

Posted in Breast Cancer, breast screening, Campaigns, cancer, citizen safety, Compassion in healthcare, death, dying, harms, healthcare modernisation, informed consent, medicine's flaws, Over-medicalisation, overdiagnosis, overtreatment, personal autonomy, Public safety, Screening, Screening Mammography | Tagged , , , | Leave a comment

Breast cancer screening – short video explains reality

TIME FOR HONESTY – This short video presents the true picture of breast screening programmes in a very easy to understand format. How shocking that this harmful ‘industry’ is allowed to continue (NHS BSP) and the age limit extended at … Continue reading

Posted in biopsies, Breast Cancer, breast screening, Campaigns, cancer, citizen safety, clinical trials, Compassion in healthcare, harms, HCAIs, healthcare modernisation, information, informed consent, mastectomy, medicine's flaws, Over-medicalisation, overdiagnosis, overtreatment, patient safety, patient/doctor communication, Primary care, Public safety, Screening, Screening Mammography, speaking out, Uncategorized, video | Tagged , , , , , , | 5 Comments

Diagnostic shades of grey

How many patients (and doctors) are unaware of the range of variability in diagnoses that can derive from the same pathology sample? How much accepted ‘certainty’ is, in fact, ‘uncertain’? Read on, and you may never want to accept a … Continue reading

Posted in biopsies, Breast Cancer, breast screening, Campaigns, cancer, citizen safety, diagnoses, harms, healthcare modernisation, information, medicine's flaws, Over-medicalisation, overdiagnosis, patient safety, patient/doctor communication, Public safety, Screening, Screening Mammography | Tagged , , , | Leave a comment

Breast cancer screening – DCIS and the COMET trial

Women diagnosed with Ductal Carcinoma in Situ (DCIS) are usually offered lumpectomy or mastectomy as standard treatment, although DCIS is not usually recognised as an actual cancer, but rather cell changes which may or may not become cancerous in the … Continue reading

Posted in Breast Cancer, breast screening, Campaigns, citizen safety, clinical trials, Compassion in healthcare, harms, healthcare modernisation, information, informed consent, mastectomy, medicine's flaws, Over-medicalisation, overdiagnosis, overtreatment, patient safety, patient/doctor communication, Screening, Screening Mammography | Tagged , , , | Leave a comment

The evolving cancer drugs fund

‘The evolution of the cancer drug appraisal process: hosted by BMJ, this promotional campaign article by Roche includes ‘How will it work?’, ‘Implications for breast cancer’, and ‘consequences for HER2+ breast cancer – coming soon’. ‘…A new model was introduced … Continue reading

Posted in Breast Cancer, Campaigns, cancer drugs, healthcare modernisation, patient safety | Tagged , , | Leave a comment